See more : Powerwrap Limited (PWL.AX) Income Statement Analysis – Financial Results
Complete financial analysis of CUC Inc. (9158.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CUC Inc., a leading company in the Healthcare industry within the Healthcare sector.
- QED Connect, Inc. (QEDN) Income Statement Analysis – Financial Results
- Coelacanth Energy Inc. (CEI.V) Income Statement Analysis – Financial Results
- Mitsuuroko Group Holdings Co.,Ltd. (8131.T) Income Statement Analysis – Financial Results
- ASI INDUSTRIES LIMITED (ASIIL.BO) Income Statement Analysis – Financial Results
- Clear Channel Outdoor Holdings, Inc. (C7C1.F) Income Statement Analysis – Financial Results
CUC Inc. (9158.T)
About CUC Inc.
CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consulting services. The company was founded in 2014 and is based in Minato-Ku, Japan. CUC Inc. operates as a subsidiary of M3 Inc.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 33.03B | 35.21B | 35.31B | 16.61B |
| Cost of Revenue | 17.10B | 21.43B | 21.07B | 9.05B |
| Gross Profit | 15.92B | 13.78B | 14.25B | 7.55B |
| Gross Profit Ratio | 48.21% | 39.13% | 40.34% | 45.48% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.21B | 10.02B | 8.79B | 5.71B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 12.21B | 10.02B | 8.79B | 5.71B |
| Other Expenses | -20.00M | -546.00M | -351.00M | -330.00M |
| Operating Expenses | 12.21B | 10.09B | 10.57B | 5.92B |
| Cost & Expenses | 29.29B | 31.53B | 31.64B | 14.98B |
| Interest Income | 687.00M | 50.00M | 43.00M | 30.00M |
| Interest Expense | 285.00M | 99.00M | 100.00M | 88.00M |
| Depreciation & Amortization | 1.81B | 1.22B | 1.07B | 801.00M |
| EBITDA | 6.23B | 4.95B | 4.79B | 2.46B |
| EBITDA Ratio | 18.86% | 14.07% | 13.56% | 14.82% |
| Operating Income | 3.74B | 3.68B | 3.68B | 1.63B |
| Operating Income Ratio | 11.32% | 10.46% | 10.42% | 9.81% |
| Total Other Income/Expenses | 401.00M | -127.00M | -57.00M | -57.00M |
| Income Before Tax | 4.14B | 3.63B | 3.62B | 1.57B |
| Income Before Tax Ratio | 12.53% | 10.32% | 10.26% | 9.47% |
| Income Tax Expense | 1.53B | 1.23B | 1.40B | 477.00M |
| Net Income | 2.60B | 2.42B | 2.71B | 1.10B |
| Net Income Ratio | 7.86% | 6.88% | 7.67% | 6.62% |
| EPS | 93.98 | 113.91 | 129.71 | 38.63 |
| EPS Diluted | 93.98 | 113.91 | 129.71 | 38.63 |
| Weighted Avg Shares Out | 27.61M | 21.27M | 20.87M | 28.48M |
| Weighted Avg Shares Out (Dil) | 27.61M | 21.27M | 20.87M | 28.48M |
Source: https://incomestatements.info
Category: Stock Reports